Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5195459 | 6111783 | F | 5195459-9 | 20060811 | 20061230 | EXP | DE-ABBOTT-06P-062-0340279-00 | ABBOTT | M | Y | 67 | KG | 20061230 | MD | 20060512 | GERMANY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5195459 | 1007999550 | PS | ZEMPLAR | 1 | INTRAVENOUS | UNKNOWN | 020819 | ||||
| 5195459 | 1007999551 | SS | ZEMPLAR | 1 | INTRAVENOUS | UNKNOWN | 020819 | ||||
| 5195459 | 1007999552 | SS | ZEMPLAR | 1 | INTRAVENOUS | UNKNOWN | 020819 | ||||
| 5195459 | 1007999553 | SS | ZEMPLAR | 1 | INTRAVENOUS | UNKNOWN | 020819 | ||||
| 5195459 | 1007999554 | SS | ZEMPLAR | 1 | INTRAVENOUS | UNKNOWN | 020819 | ||||
| 5195459 | 1007999555 | SS | ZEMPLAR | 1 | INTRAVENOUS | UNKNOWN | 020819 | ||||
| 5195459 | 1007999556 | C | FUROSEMIDE | 1 | ORAL | ||||||
| 5195459 | 1007999557 | C | ALUMINIUM HYDROXIDE GEL | 2 | ORAL | ||||||
| 5195459 | 1007999558 | C | VERAPAMIL HYDROCHLORIDE | 1 | ORAL | ||||||
| 5195459 | 1007999559 | C | GLYCERYL TRINITRATE | 2 | SUBLINGUAL | ||||||
| 5195459 | 1007999560 | C | MOXONIDINE | 2 | ORAL | ||||||
| 5195459 | 1007999561 | C | SIMVASTATIN | 1 | ORAL | ||||||
| 5195459 | 1007999562 | C | ESOMEPRAZOLE MAGNESIUM | 1 | ORAL | ||||||
| 5195459 | 1007999563 | C | SEVELAMER HYDROCHLORIDE | 2 | ORAL | ||||||
| 5195459 | 1007999564 | C | CLOPIDOGREL BISULFATE | 1 | ORAL |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5195459 | 1007999550 | HYPERPARATHYROIDISM SECONDARY |
| 5195459 | 1007999556 | DRUG USE FOR UNKNOWN INDICATION |
| 5195459 | 1007999557 | HYPERPARATHYROIDISM SECONDARY |
| 5195459 | 1007999558 | DRUG USE FOR UNKNOWN INDICATION |
| 5195459 | 1007999559 | DRUG USE FOR UNKNOWN INDICATION |
| 5195459 | 1007999560 | DRUG USE FOR UNKNOWN INDICATION |
| 5195459 | 1007999561 | DRUG USE FOR UNKNOWN INDICATION |
| 5195459 | 1007999562 | DRUG USE FOR UNKNOWN INDICATION |
| 5195459 | 1007999563 | DRUG USE FOR UNKNOWN INDICATION |
| 5195459 | 1007999564 | DRUG USE FOR UNKNOWN INDICATION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5195459 | DE |
| 5195459 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5195459 | ACUTE MYOCARDIAL INFARCTION |
| 5195459 | ANGINA PECTORIS |
| 5195459 | BLOOD ALKALINE PHOSPHATASE INCREASED |
| 5195459 | BLOOD PARATHYROID HORMONE INCREASED |
| 5195459 | BLOOD PHOSPHORUS INCREASED |
| 5195459 | CARDIAC FAILURE CONGESTIVE |
| 5195459 | PULMONARY CONGESTION |
| 5195459 | SHOCK |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5195459 | 1007999550 | 20060416 | 20060416 | ||
| 5195459 | 1007999551 | 20051216 | 20060109 | ||
| 5195459 | 1007999552 | 20060109 | 20060116 | ||
| 5195459 | 1007999553 | 20060116 | 20060216 | ||
| 5195459 | 1007999554 | 20060216 | 20060316 | ||
| 5195459 | 1007999555 | 20060316 | 20060416 |